CG Oncology Inc. ( CGON) - Key Metrics
CGON Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.90 | -$0.53 | -$0.53 |
| 2026Q1 | $0.01 | -$0.71 | -$0.67 | -$0.68 |
| 2025Q4 | $0.03 | -$0.53 | -$0.47 | -$0.47 |
| 2025Q3 | $0.02 | -$0.57 | -$0.51 | -$0.51 |
| 2025Q2 | $0 | -$0.54 | -$0.37 | -$0.37 |
CGON Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -19.74 |
| 2026Q1 | 0% | -23.83 |
| 2025Q4 | 0% | -19.96 |
| 2025Q3 | 0% | -17.67 |
| 2025Q2 | 0% | -12.04 |
CGON
Price: $75.03
52 week price:
Earnings Per Share: -2.69 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.8 billion